1Inoh M,Tokuda M,Kiuchi H,et al.Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis[].Arthritis and Rheumatism.1996 被引量：1
2Ichikawa Y,Yamada C,Horiki T,et al.Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis[].Clinical and Experimental Rheumatology.1998 被引量：1
3Out HJ,Groot PGD,Hasselaar P.Fluctuation of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study[].Annals of the Rheumatic Diseases.1989 被引量：1
5Tomas JF,Alberca I,Tabernero MD,et al.Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus[].The Journal of Rheumatology.1998 被引量：1
6Shinichi O,Shogo T,Nobuo A.Plasma thrombomodulin as a marker of vascular injuries in collagen vascular disease[].American Journal of Clinical Pathology.1994 被引量：1
同被引文献4
1Min DJ,Kim SJ,Pank SH,et al.Anti-nucleosome antibody:significance in lupus patients lacking anti-double-stranded DNA antibody.Clinicaland Experimental Rheumatology,2012,22(34):23-24. 被引量：1
